Published in Eur J Cancer on July 01, 1997
Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc (2010) 2.66
Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale. Am J Manag Care (2010) 1.32
Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results. Health Expect (2002) 1.30
Informed decision making in maternity care. J Perinat Educ (2009) 1.26
Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer (2008) 1.21
Patient preference and satisfaction with their involvement in the selection of an anesthetic method for surgery. J Korean Med Sci (2014) 1.13
Evaluation and ethical review of a tool to explore patient preferences for information and involvement in decision making. J Med Ethics (2006) 1.09
Development and validation of the Japanese version of the Decisional Conflict Scale to investigate the value of pharmacists' information: a before and after study. BMC Med Inform Decis Mak (2013) 0.98
Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients. PLoS One (2014) 0.97
Too complex and time-consuming to fit in! Physicians' experiences of elderly patients and their participation in medical decision making: a grounded theory study. BMJ Open (2012) 0.96
Are elderly people with co-morbidities involved adequately in medical decision making when hospitalised? A cross-sectional survey. BMC Geriatr (2011) 0.96
Measurement of self-advocacy in cancer patients and survivors. Support Care Cancer (2008) 0.90
Patient-centred care: making cancer treatment centres accountable. Support Care Cancer (2014) 0.82
Health literacy, numeracy, and other characteristics associated with hospitalized patients' preferences for involvement in decision making. J Health Commun (2014) 0.80
Oncologists' assessments of lung cancer patient and family disagreements regarding treatment decision making. Lung Cancer (2012) 0.79
Differences between patient and provider perceptions of informed decision making about epidural analgesia use during childbirth. J Perinat Educ (2014) 0.78
Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences. J Cancer Educ (2016) 0.77
Understanding patient preferences for involvement in care. Eur J Cancer (1997) 0.75
Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev (2005) 3.88
Emergency ultrasound-based algorithms for diagnosing blunt abdominal trauma. Cochrane Database Syst Rev (2005) 2.28
Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis (1992) 1.98
Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer (1997) 1.85
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol (2005) 1.71
Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis (2001) 1.53
Acquisition of Helicobacter pylori infection in a high-risk population occurs within the first 2 years of life. J Pediatr (2000) 1.53
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
[Evidence-based medicine and anaesthesiology--six steps towards implementation into clinical practice]. Anasthesiol Intensivmed Notfallmed Schmerzther (2003) 1.37
Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res (2001) 1.36
Targeted therapy for advanced renal cell carcinoma. Cochrane Database Syst Rev (2008) 1.35
A likelihood ratio approach to meta-analysis of diagnostic studies. J Med Screen (2003) 1.30
Systematic review and meta-analysis of emergency ultrasonography for blunt abdominal trauma. Br J Surg (2001) 1.20
Dissociation and reassembly of adherens junctions during experimental acute pancreatitis. Gastroenterology (1997) 1.19
Supramaximal cholecystokinin displaces Munc18c from the pancreatic acinar basal surface, redirecting apical exocytosis to the basal membrane. J Clin Invest (2001) 1.16
[Emergency ultrasound for blunt abdominal trauma--meta-analysis update 2003]. Zentralbl Chir (2003) 1.15
Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. Blood (1989) 1.14
Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulation. Am J Physiol (1995) 1.10
Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. Int J Epidemiol (1998) 1.09
Early retirement due to permanent disability in relation to smoking in workers of the construction industry. J Occup Environ Med (1998) 1.07
Practical aspects of quality-of-life measurement: design and feasibility study of the quality-of-life recorder and the standardized measurement of quality of life in an outpatient clinic. Cancer Treat Rev (1996) 1.05
Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Cancer Treat Res (2007) 1.02
Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev (2000) 0.96
High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest (1992) 0.93
Integrin alpha6beta1 role in metastatic behavior of human pancreatic carcinoma cells. Int J Cancer (1999) 0.93
Disorders of the back and spine in construction workers. Prevalence and prognostic value for disability. Spine (Phila Pa 1976) (1997) 0.93
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial. Ann Oncol (2011) 0.93
Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood (1991) 0.92
Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol Ther (1996) 0.90
Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res (1998) 0.89
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man. J Clin Endocrinol Metab (1994) 0.87
Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors. Am J Physiol (1999) 0.87
Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol (1997) 0.86
Tolerance to the effects of daily nicotine on rat bar pressing behavior for water reinforcement. Pharmacol Biochem Behav (1974) 0.86
Delta9-tetrahydrocannabinol and some CNS depressants: evidence for cross-tolerance in the rat. Arch Int Pharmacodyn Ther (1974) 0.86
Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas. Ann Hematol (1991) 0.85
Stimulation of human NK-cell activity by cultured cells. I. Response of normals. Int J Cancer (1978) 0.85
Subcellular distribution and function of Rab3A-D in pancreatic acinar AR42J cells. Biochem Biophys Res Commun (2001) 0.85
[Challenge of evidence-based medicine: sense and non-sense of diagnostic tests in gynecology]. Zentralbl Gynakol (2001) 0.84
Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation (1987) 0.83
Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia. Leuk Lymphoma (1995) 0.83
[Detection of tumorantigens of hypernephroma (author's transl)]. Urol Int (1973) 0.82
Fibroblasts stimulate acinar cell proliferation through IGF-I during regeneration from acute pancreatitis. Am J Physiol (1999) 0.82
[Spontaneous remission of sudden deafness]. HNO (2000) 0.81
[Methods of health economic evaluation for health services research]. Gesundheitswesen (2010) 0.81
p53 mutations in hairy cell leukemia. Leukemia (2000) 0.81
Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease. Qual Life Res (2001) 0.81
9 -Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat. Science (1972) 0.81
Natural killer cell activity in preleukaemia. Lancet (1982) 0.81
Interferon-alpha antibodies in autoimmune diseases. J Interferon Res (1989) 0.81
Active infection with Helicobacter pylori in an asymptomatic population of middle aged to elderly people. Epidemiol Infect (1998) 0.80
The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog. Drug Metab Dispos (1986) 0.80
Impaired natural killer cell function in hemophiliacs with or without continuous substitution. Blut (1984) 0.80
The electrophoretic mobility test (EMT) and cancer diagnosis. Z Immunitatsforsch Immunobiol (1978) 0.80
Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Lancet (1990) 0.80
History of antibiotic treatment and prevalence of H. pylori infection among children: results of a population-based study. J Clin Epidemiol (1998) 0.79
Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation. Bone Marrow Transplant (1996) 0.79
Regulation of adherens junction protein p120(ctn) by 10 nM CCK precedes actin breakdown in rat pancreatic acini. Am J Physiol Gastrointest Liver Physiol (2000) 0.79
Expression of the protooncogene jun is induced in the rat pancreas by cerulein infusion. Pancreas (1997) 0.78
Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. Leukemia (1990) 0.78
Physicians' decision-making in incompetent elderly patients: a comparative study between Austria, Germany (East, West), and Sweden. Int Psychogeriatr (1999) 0.78
Bone densitometry and histomorphometry in patients with hairy cell leukemia. Leuk Lymphoma (1994) 0.78
[Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies]. Dtsch Med Wochenschr (2007) 0.78
Impaired T-cell and NK-cell function in patients with preleukemia. Blut (1982) 0.78
High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant (1994) 0.78
[Lay assessment of health care services using therapy for rectal cancer as an example]. Zentralbl Chir (2008) 0.78
Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in hairy cell leukaemia. Br J Haematol (1997) 0.77
Observations regarding hairy cell leukemia and chronic lymphocytic leukemia within the proposed new classification of lymphoid neoplasms. Blood (1995) 0.77
High affinity binding sites for proinsulin in human IM-9 lymphoblasts. Diabetologia (1996) 0.77
Tumour necrosis factor and hairy cell leukaemia. Lancet (1988) 0.76
Commercial mouse and human nerve growth factors contain nerve growth factor prohormone isoforms. J Neurosci Methods (1997) 0.76
A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia. Blut (1989) 0.76
Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo. Blood (1990) 0.76
Dyspepsia in relation to Helicobacter pylori infection and psychosocial work stress in white collar employees. Am J Gastroenterol (1998) 0.76
Endoscopic insertion of an M2A video capsule through an overtube. Endoscopy (2005) 0.75
Neurophysiological effects of recombinant interferon-gamma and -alpha in man. Clin Physiol Biochem (1989) 0.75
Stimulation of human NK cell activity by cultured cells. II Ingestion of aspirin by blood donors suppresses induced NK activity. Clin Exp Immunol (1981) 0.75
When should hairy cell leukaemia be treated? Lancet (1990) 0.75
The clinical evaluation of hairy cell leukemia. Blood (1992) 0.75
[What is the benefit of mammography? -- mammography screening: careful consideration required]. Dtsch Med Wochenschr (2013) 0.75
Considerations on the pathogenesis of acute myeloid leukaemia in a splenectomized hairy cell leukaemia patient treated with interferon-alpha. Br J Haematol (1994) 0.75
Cholecystokinin-induced redistribution of paxillin in rat pancreatic acinar cells. Biochem Biophys Res Commun (1999) 0.75
Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemia. Br J Haematol (1995) 0.75
[Highlights of the 38th Annual Congress of the American Society of Clinical Oncology ASCO 2002]. Z Gastroenterol (2002) 0.75
Endocrine effects of recombinant interleukin 6 in man. Neuroendocrinology (1996) 0.75
Recombinant interferon-alpha 2 antibodies in renal cell carcinoma. Delta-P Study Group. J Interferon Res (1994) 0.75
[Placebo-surgery between "efficacy" and "evidence"]. Zentralbl Chir (1999) 0.75
[Physicians' attitude in the treatment of incompetent patients. Comparison between East and West Germany]. Med Klin (Munich) (1997) 0.75
Some evidence for long term memory retention by orotic acid in rats bar pressing for water. Arch Int Pharmacodyn Ther (1974) 0.75
Cyclosporin A inhibits cytokine-induced proliferation in B-chronic lymphocytic leukemia. Leuk Lymphoma (1994) 0.75
[ASCO Update 2003 - Highlights of the 39th Meeting of the American Society of Clinical Oncology/ASCO 2003]. Z Gastroenterol (2003) 0.75
High-titer interferon-alpha antibodies in a patient with pemphigus foliaceus. Exp Dermatol (1996) 0.75
Correlation of elevated plasma soluble IL-2 receptor levels with defective NK and CD8+ T-cells in myelodysplastic syndromes: is it part of a spectrum? Leuk Res (1995) 0.75
[Multimodal therapy in colon carcinoma]. Internist (Berl) (2003) 0.75
[Ethics and/or evidence-based psychotherapy--a challenge]. Psychother Psychosom Med Psychol (2000) 0.75
[ASCO update -- highlights of the 40th Meeting of the American Society of Clinical Oncology/ASCO 2004]. Z Gastroenterol (2004) 0.75
Symposium on health economics in oncology. Freiburg, Germany, June 1995. J Cancer Res Clin Oncol (1995) 0.75